Related Experiment Videos
Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma
S F Freedman1, K McCormick, T A Cox
1Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, USA.
Summary
Mitomycin C-augmented trabeculectomy shows a 52.4% success rate in pediatric glaucoma, with better outcomes in older, phakic children. Postoperative treatments like 5-fluorouracil and laser suture lysis did not significantly improve success and may increase complications.
Area of Science:
- Ophthalmology
- Pediatric Surgery
Background:
- Pediatric glaucoma presents unique challenges due to the developing visual system.
- Refractory cases often require surgical intervention beyond initial treatments.
Purpose of the Study:
- To evaluate the efficacy of mitomycin C-augmented trabeculectomy combined with postoperative 5-fluorouracil and laser suture lysis.
- To assess treatment outcomes in pediatric patients with refractory glaucoma.
Main Methods:
- Retrospective review of 21 cases (17 patients) with refractory pediatric glaucoma.
- Treatment included mitomycin C trabeculectomy with postoperative 5-fluorouracil, laser suture lysis, or both.
- Success defined as intraocular pressure (IOP) between 4-16 mm Hg without further surgery.
Main Results:
- Overall success rate was 52.4% with a median follow-up of 23 months.
- Success rates were higher in older children (>1 year: 73%) versus infants (<1 year: 30%) and in phakic (64%) versus aphakic eyes (29%).
- Age and lens status were significant predictors of outcome; complications were common.
Conclusions:
- Mitomycin C-augmented trabeculectomy is a viable option for older, phakic children with refractory glaucoma.
- The procedure has lower success rates in infants and aphakic eyes.
- Postoperative complications are frequent, necessitating long-term follow-up; added treatments did not convincingly improve success and may increase complications.